FDA OKs New Option for Primary Biliary Cholangitis
MedPage Today) -- The FDA granted accelerated approval to seladelpar (Livdelzi) for adults with primary biliary cholangitis (PBC), a rare...
Gaylene Motsinger
MedPage Today) -- The FDA granted accelerated approval to seladelpar (Livdelzi) for adults with primary biliary cholangitis (PBC), a rare...
